Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1a315eb173065fb5ad342762416ab8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c784728679e4855659cd8f27416644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_332bfd9f6e8b872899d987f0818de269 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b69ab3e66d84b6f8246815014498756 |
publicationDate |
2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114008033-A |
titleOfInvention |
Glucagon-like peptide 1 receptor agonists |
abstract |
In one embodiment, the present invention provides compounds of the formula: or a pharmaceutically acceptable salt thereof, and methods of using such compounds for the treatment of type II diabetes. |
priorityDate |
2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |